3-(4-tert-Butylphenyl)-3-oxo-propionic acidmethyl ester, 95+%, 1g

4-Aminocyclohexanone Hydrochloride>98.0%(T)1g

4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine, 95.0%, 5g

2-Bromo-9,9-difluoro-9H-fluorene, 98%, 50mg

2-PHENYL-2H-PYRAZOLO[3,4-D]PYRIDAZIN-7(6H)-ONE, 95.0%, 250mg

cis-1-Propenylbenzene, 98.0%, 5g

(2S)-[(TERT-BUTOXYCARBONYL)AMINO](4-HYDROXYPHENYL)ETHANOIC ACID, 95.0%, 5g

5-cyclobutyl-1,3,4-oxadiazol-2-amine, 95.0%, 1g

Ethyl 3-(4-nitrophenyl)-3-oxopropanoate, 95.0%, 5g

GC capillary column ROTI®Cap-1701, 10 m, 0.53 mm, 1.00 µm, 1 Piece(s)

(S)-1-Methyl-4-(pyrrolidin-3-yl)piperazine, 97%, 1g

4-Bromo-2-isopropyl-2H-1,2,3-triazole, 250mg

3-(tert-Butyl)-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione, 97%, 25g